AR054394A1 - Derivados de 2- (1h-indolilsulfanil)-aril amina - Google Patents

Derivados de 2- (1h-indolilsulfanil)-aril amina

Info

Publication number
AR054394A1
AR054394A1 ARP060102491A ARP060102491A AR054394A1 AR 054394 A1 AR054394 A1 AR 054394A1 AR P060102491 A ARP060102491 A AR P060102491A AR P060102491 A ARP060102491 A AR P060102491A AR 054394 A1 AR054394 A1 AR 054394A1
Authority
AR
Argentina
Prior art keywords
alkyl
cycloalkyl
group
amino
independently
Prior art date
Application number
ARP060102491A
Other languages
English (en)
Spanish (es)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR054394A1 publication Critical patent/AR054394A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP060102491A 2005-06-17 2006-06-13 Derivados de 2- (1h-indolilsulfanil)-aril amina AR054394A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69200905P 2005-06-17 2005-06-17

Publications (1)

Publication Number Publication Date
AR054394A1 true AR054394A1 (es) 2007-06-20

Family

ID=37532681

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102491A AR054394A1 (es) 2005-06-17 2006-06-13 Derivados de 2- (1h-indolilsulfanil)-aril amina

Country Status (15)

Country Link
EP (1) EP1893575B1 (cg-RX-API-DMAC7.html)
JP (1) JP5144507B2 (cg-RX-API-DMAC7.html)
KR (1) KR20080027462A (cg-RX-API-DMAC7.html)
CN (1) CN101238101A (cg-RX-API-DMAC7.html)
AR (1) AR054394A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006257288A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0611748A2 (cg-RX-API-DMAC7.html)
CA (1) CA2611566C (cg-RX-API-DMAC7.html)
EA (1) EA200800070A1 (cg-RX-API-DMAC7.html)
ES (1) ES2616095T3 (cg-RX-API-DMAC7.html)
IL (1) IL188064A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007014954A (cg-RX-API-DMAC7.html)
NO (1) NO20080265L (cg-RX-API-DMAC7.html)
WO (1) WO2006134499A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200710885B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010540461A (ja) * 2007-09-24 2010-12-24 ハー・ルンドベック・アクチエゼルスカベット セロトニン二重作用化合物に関する併用療法
TW200938189A (en) * 2008-03-13 2009-09-16 Lundbeck & Co As H [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
EP2606031B1 (en) 2010-08-20 2017-09-27 Amira Pharmaceuticals, Inc. Autotaxin inhibitors and uses thereof
US9260416B2 (en) 2011-05-27 2016-02-16 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
US10179781B2 (en) * 2013-03-15 2019-01-15 Chromocell Corporation Sodium channel modulators for the treatment of pain
EP3046909A4 (en) 2013-09-17 2017-03-29 Pharmakea, Inc. Heterocyclic vinyl autotaxin inhibitor compounds
US9714240B2 (en) 2013-09-17 2017-07-25 Pharmakea, Inc. Vinyl autotaxin inhibitor compounds
US9850203B2 (en) 2013-09-26 2017-12-26 Pharmakea, Inc. Autotaxin inhibitor compounds
PE20160654A1 (es) 2013-11-22 2016-07-15 Pharmakea Inc Compuestos de inhibidor de autotaxina
CN116059203A (zh) 2015-05-27 2023-05-05 赛博治疗有限责任公司 自分泌运动因子抑制剂及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117129A (en) * 1976-10-22 1978-09-26 Warner-Lambert Company Indolobenzoxazepines as cns depressants
ATE195125T1 (de) * 1995-11-06 2000-08-15 Dsm Nv Verfahren zur de-esterifikation
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
TW200400177A (en) * 2002-06-04 2004-01-01 Wyeth Corp 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
EP1701940B1 (en) * 2003-12-23 2008-05-28 H.Lundbeck A/S 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto

Also Published As

Publication number Publication date
EA200800070A1 (ru) 2008-04-28
BRPI0611748A2 (pt) 2016-11-22
KR20080027462A (ko) 2008-03-27
ZA200710885B (en) 2009-03-25
WO2006134499A3 (en) 2007-04-12
NO20080265L (no) 2008-01-15
JP5144507B2 (ja) 2013-02-13
WO2006134499A2 (en) 2006-12-21
MX2007014954A (es) 2008-02-15
CA2611566C (en) 2011-08-16
EP1893575B1 (en) 2017-01-11
ES2616095T3 (es) 2017-06-09
CA2611566A1 (en) 2006-12-21
EP1893575A2 (en) 2008-03-05
JP2008546679A (ja) 2008-12-25
CN101238101A (zh) 2008-08-06
AU2006257288A1 (en) 2006-12-21
IL188064A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
CR20160127A (es) Pesticidas de azoles bicíclicos sustituidos con heterociclos
ES2656793T3 (es) Salicilatos acetilados de ácidos grasos y sus usos
CL2022001529A1 (es) Nuevos derivados de metilquinazolinona
CU20200080A7 (es) Kit que comprende un inhibidor de lats para el suministro ocular
NI201900029A (es) COMPUESTOS DE BENZO[b]TIOFENO COMO AGONISTAS DE STING
PE20211333A1 (es) Compuestos de sulfonamidaurea novedosos
AR049443A1 (es) Derivados de pirrolpiridinas
CL2023002429A1 (es) Derivados novedosos de pirimidin-2-il sulfonamida
PE20210548A1 (es) Derivado de amino-fluoropiperidina como inhibidor de quinasa
PE20212253A1 (es) Compuestos de piperidina urea 4-metilsulfonil-sustituidos para el tratamiento de miocardiopatia dilatada (mcd)
MX2009006286A (es) Composiciones plaguicidas.
CO6450621A2 (es) Sulfonamidas nematocidas
AR110768A1 (es) Formas cristalinas de tenofovir alafenamida
UY29047A1 (es) Derivados de sulfonamidas, su preparación y su aplicación en terapéutica
MX2018003311A (es) Ácido nucleico artificial puenteado a guanidina, entrelazado, método para la producción del mismo, y compuesto intermediario.
AR089623A1 (es) Inhibidores de iap
UY38941A (es) Nuevas sulfiliminas o sulfoximinas que contienen compuestos heterocíclicos fungicidas
MX2018007102A (es) Pesticidas de azol biciclicos sustituidos con heterociclo.
CL2020000376A1 (es) Compuesto pentacíclico.
MX383577B (es) Derivados sustituidos de guanidina.
MX2021007505A (es) Síntesis de 3-metil-1,2,4-tiadiazol-5-carbohidrazida o de su forma deuterada con metil-d3.
UY38397A (es) Nuevos oxadiazoles
DOP2006000234A (es) Inhibidores de cinasa
MX2019000103A (es) Profarmacos de fosforo de estimuladores de guanilato ciclasa soluble (sgc).
UY38053A (es) Mejoras en compuestos orgánicos o relacionadas con estos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal